1. Home
  2. JAGX vs VSME Comparison

JAGX vs VSME Comparison

Compare JAGX & VSME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

HOLD

Current Price

$0.60

Market Cap

4.9M

Sector

Health Care

ML Signal

HOLD

Logo VS Media Holdings Limited

VSME

VS Media Holdings Limited

HOLD

Current Price

$1.08

Market Cap

5.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
JAGX
VSME
Founded
2013
2013
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
5.0M
IPO Year
2014
2022

Fundamental Metrics

Financial Performance
Metric
JAGX
VSME
Price
$0.60
$1.08
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$60.00
N/A
AVG Volume (30 Days)
173.3K
42.5K
Earning Date
04-07-2026
10-31-2025
Dividend Yield
N/A
N/A
EPS Growth
82.42
N/A
EPS
N/A
N/A
Revenue
$11,511,000.00
N/A
Revenue This Year
$61.58
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.07
52 Week High
$8.00
$5.38

Technical Indicators

Market Signals
Indicator
JAGX
VSME
Relative Strength Index (RSI) 28.51 37.08
Support Level $0.60 $0.83
Resistance Level $1.04 $1.05
Average True Range (ATR) 0.10 0.07
MACD 0.02 -0.01
Stochastic Oscillator 2.47 3.83

Price Performance

Historical Comparison
JAGX
VSME

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

About VSME VS Media Holdings Limited

VS Media Holdings Ltd manages a network of digital Creators who create and publish content to social media platforms such as YouTube, Facebook, Instagram, and TikTok. Its Creators include influencers, KOLs-Key Opinion Leaders, bloggers, and other content creators who cultivate fan bases on social media platforms. The company's business provides value to two business stakeholders: marketing services and social commerce. The firm generates almost all of its revenue from marketing services, which reflects the company's business of marketing services to clients and social media platforms. The social commerce segment reflects the company's business of social commerce with customers. Geographically, the firm generates revenue from the HK SAR and Taiwan.

Share on Social Networks: